Clinical trial
Randomized Double-Blind Placebo Controlled Study of Testosterone in the Adjuvant Treatment of Postmenopausal Women With Aromatase Inhibitor Induced Arthralgias
NCT01573442 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Double-Blind Placebo Controlled Study of Testosterone in the Adjuvant Treatment of Postmenopausal Women With Aromatase Inhibitor Induced Arthralgias
- Lead sponsor
- Alliance for Clinical Trials in Oncology
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 10, 2013
- Completion date
- September 1, 2019
- Enrollment
- 227 (actual)
- Sites
- 529
Conditions
As the registry lists them; a condition with its own page is linked.
arthralgia, breast cancer, hot flashes, musculoskeletal complications, sexual dysfunction